Table 1 Clinical characteristics of patients (N = 18)
Characteristic | N (%) |
|---|---|
Sex (Male) | 13 (72.2) |
Age (> 65 years) | 13 (72.2) |
Department | Â |
Respiratory | 5 (27.8) |
Neurological | 4 (22.2) |
ICU | 3 (16.7) |
Neurosurgery | 3 (16.7) |
Chinese traditional medicine | 1 (5.6) |
Rehabilitation medicine | 1 (5.6) |
Rheumatic immunology | 1 (5.6) |
Specimen types | Â |
Sputum | 15 (83.3) |
Urine | 2 (11.1) |
Blood | 1 (5.6) |
ICU admission within 30 days before strain culture | 9 (50) |
Blood transfusion within 30 days before strain culture | 3 (16.7) |
Hospitalized for more than 14 days | 16 (88.9) |
Underlying diseases | Â |
Brain diseases | 17 (94.4) |
Respiratory diseases | 17 (94.4) |
Hypertension | 10 (55.6) |
Heart diseases | 9 (50.0) |
Diabetes | 3 (16.7) |
Digestive system diseases | 3 (16.7) |
Urinary system diseases | 3 (16.7) |
Cancer | 2 (11.1) |
Immune system diseases | 1 (5.6) |
Complicated with fungal infection | 1 (5.6) |
Treatment received before strain culture | Â |
Multiple antibiotics | 14 (77.8) |
β-lactamase inhibitors | 10 (55.6) |
Carbapenems | 9 (50.0) |
3rd or 4th generation Cephalosporins | 7 (38.9) |
Corticosteroids and immunosuppressants | 5 (27.8) |
Quinolones | 5 (27.8) |
Tetracyclines | 3 (16.7) |
Polypeptides | 3 (16.7) |
Aminoglycosides | 2 (11.1) |
Invasive procedure within 90 days before strain culture | Â |
Urinary catheter | 12 (66.7) |
Tracheal intubation | 8 (44.4) |
Mechanical ventilation | 7 (38.9) |
Tracheostomy | 5 (27.8) |
Arteriovenous catheterization | 3 (16.7) |